For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Enliven Therapeutics Inc (NASDAQ: ELVN) closed at $20.17 up 3.49% from its previous closing price of $19.49. In other words, the price has increased by $3.49 from its previous closing price. On the day, 1.1 million shares were traded. ELVN stock price reached its highest trading level at $20.47 during the session, while it also had its lowest trading level at $19.29.
Ratios:
For a deeper understanding of Enliven Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 32.95 and its Current Ratio is at 32.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on June 16, 2025, initiated with a Buy rating and assigned the stock a target price of $37.
On December 13, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $42.
On September 09, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $37.H.C. Wainwright initiated its Buy rating on September 09, 2024, with a $37 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 08 ’25 when Patel Anish sold 6,663 shares for $21.02 per share. The transaction valued at 140,073 led to the insider holds 263,311 shares of the business.
Patel Anish bought 6,663 shares of ELVN for $145,320 on Dec 08 ’25. On Nov 19 ’25, another insider, Lyssikatos Joseph P, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 12,500 shares for $22.33 each. As a result, the insider received 279,155 and left with 902,688 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELVN now has a Market Capitalization of 1197035392 and an Enterprise Value of 719960384.
Stock Price History:
The Beta on a monthly basis for ELVN is 0.39, which has changed by -0.1526087 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, ELVN has reached a high of $25.37, while it has fallen to a 52-week low of $13.30. The 50-Day Moving Average of the stock is -3.15%, while the 200-Day Moving Average is calculated to be 0.76%.
Shares Statistics:
For the past three months, ELVN has traded an average of 570.67K shares per day and 613270 over the past ten days. A total of 59.26M shares are outstanding, with a floating share count of 43.25M. Insiders hold about 27.12% of the company’s shares, while institutions hold 77.97% stake in the company. Shares short for ELVN as of 1764288000 were 7996827 with a Short Ratio of 14.01, compared to 1761868800 on 7782638. Therefore, it implies a Short% of Shares Outstanding of 7996827 and a Short% of Float of 19.18.
